A device developed for people with paralysis, progressive muscle-diseases or arm amputations. Enables the person to operate a computer solely by using his or her mouth. The slightest movement of the lips will control the mouthpiece and move the mouse across the computer screen. By simply sipping and puffing, the person can trigger mouse clicks as with any standard mouse.
Decision support system running on a real-time cloud computing platform enables physicians to improve the diagnosis and treatment of Attention Deficit Hyperactive Disorder (ADHD) in children and adolescents. At the same time providing support for parents and teachers that are daily confronted with the disorder.
A portable and user-friendly point of care device at an affordable price for self-management of chronic asthma condition, the most common disease among children. Effective management of long-term control medications will reduce the abuse of relieve medication and enable better quality of life for patients. The device won’t require a complex configuration and function by analysing biomarkers in exhaled breath.
Identification of the root cause of Attention Deficit Hyperactivity Disorder (ADHD) for a given child and personalised treatment on an affordable and user-friendly device, enabling optimal training at home under remote medical supervision. It delivers an alternative to treatment by psychoactive medication providing physiological lasting normalisation of brain activity using the child’s endogenous neuronal plasticity normalising social behaviour and improving school performance.
Therapeutic software for cognitive-communication disorders aids early-age ASD (autism spectrum disorder) children in their transition from a piece of paper to an electronic device, giving them a chance to learn new skills and be independent. A secure communication platform with real-time data enables customisation and access to feedback on performance, implementing new professional therapies and technological improvements.
The vaccine candidate comprises five recombinant antigens corresponding to highly conserved merozoite surface proteins (including sub-regions) of two major parasite species that infect humans. Inducing satisfactory immune responses being one of the objectives, positive results have been reached during extensive efficacy testing in primates.
Scroll down to see more